Cell line · CVCL_0630
SK-MES-1
Cancer cell line, Homo sapiens. Lung squamous cell carcinoma. 49 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SK-MES-1. Cell lines, record CVCL_0630. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0630
On this page
Cell line
As Cellosaurus gives it.
- Name
- SK-MES-1
- Accession
- CVCL_0630
- RRID
- RRID:CVCL_0630
- Synonyms
- SK MES 1, SKMES-1, SK-Mes-1, SK-MES1, SKMES1, SK-MES, SKMES
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 65Y
- Category
- Cancer cell line
- Diseases
- Lung squamous cell carcinoma (NCIt C3493)
- Derived from
- Pleural effusion (metastatic)
- Secondary accessions
- CVCL_8913
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers49
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Circulating Tumour Cell GALNT13 Expression Is Associated with Prognosis and Treatment Response in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ZUP1 contributes to cisplatin resistance and treg-related signaling in non-small cell lung cancer. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Silencing of BCAT1 induces ferroptosis and inhibits brain metastasis of non-small cell lung cancer via activating the cGAS-STING pathway. | J Thorac Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Covalent Inhibition of SHMT2 by Gambogic Acid Induces Ferroptosis Through Mitochondrial Collapse in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non-Small Cell Lung Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome. | Immunity | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HNRNPA2B1 confers immune escape of non-small cell lung cancer through targeting lactate/ferroptosis. | Cell Death Dis | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 49
See all 49 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | RERF-LC-MA | CVCL_3153 | Has a recorded problem | Cell lines |
| Derived from it | SK-MES-1-Luc | CVCL_C8XL | Cell lines | |
| Derived from it | SKMES-1-Taxol | CVCL_X336 | Cell lines | |
| Derived from it | SKMES-1-Taxotere | CVCL_X337 | Cell lines | |
| Derived from it | Ubigene SK-MES-1 SNORA59B KO | CVCL_E1C9 | Cell lines |
Cell banks14
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-58 | ATCC | |
| AddexBio | C0016029/4989 | Cellosaurus | |
| CLS | 300339 | CLS | |
| CancerTools | 161935 | CancerTools | |
| DSMZ | ACC-353 | DSMZ | |
| ECACC | 91091804 | Discontinued | Cellosaurus |
| ECACC | 93120837 | ECACC | |
| ICLC | HTL95004 | ICLC | |
| IZSLER | BS TCL 72 | Cellosaurus | |
| KCB | KCB 200821YJ | Cellosaurus |
1 to 10 of 14
See all 14 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0630
GET https://conductscience.org/api/cell-lines/v1/CVCL_0630/papers?page=2